JPRN-UMIN000047390尚未招募未知
Multicenter prospective study of Diverticulitis of the colon - Multicenter prospective study of Diverticulitis of the colon
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 120years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients denied colonic diverticulitis by imaging examinations
研究者
相似试验
进行中（未招募）
不适用
A Randomized, Double-Blind, Multicenter Study of Denosumab Compared with Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Men with Hormone-Refractory Prostate Cancer.EUCTR2006-000341-19-GRAmgen Inc1,700
进行中（未招募）
不适用
Double-blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Men With Hormone-refractory Prostate CancerEUCTR2006-000341-19-SEAmgen Inc1,904
进行中（未招募）
1 期
A Randomized, Double-Blind, Multicenter Study of Denosumab ComparedWith Zoledronic Acid (Zometa) in the Treatment of Bone Disease inSubjects with Newly Diagnosed Multiple MyelomaMultiple MyelomaEUCTR2010-020454-34-ITAMGEN INC.1,718
已完成
3 期
A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Subjects with Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple MyelomaBone Metastases in Subjects with Advanced Cancer (Excluding Breast and Prostate Cancer) and Multiple Myeloma. Cancer (Except Breast and Prostate Cancer) spread to bone and Kahler's disease.1000595910027656NL-OMON30155Amgen Inc.18
进行中（未招募）
1 期
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple MyelomaMedDRA version: 20.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2010-020454-34-GBAmgen Inc1,700